A Comparison of Subgroup Analyses in Grant Applications and Publications

被引:11
作者
Boonacker, Chantal W. B. [1 ]
Hoes, Arno W. [1 ]
van Liere-Visser, Karen [2 ]
Schilder, Anne G. M. [1 ,3 ]
Rovers, Maroeska M. [1 ,3 ]
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
[2] Netherlands Org Hlth Res & Dev ZonMw, The Hague, Netherlands
[3] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Utrecht, Netherlands
关键词
analysis; epidemiologic methods; publications; research; statistics; RANDOMIZED CLINICAL-TRIALS; COVARIATE ADJUSTMENT; EXPLANATION; RISKS; ABUSE;
D O I
10.1093/aje/kwr075
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In this paper, the authors compare subgroup analyses as outlined in grant applications and their related publications. Grants awarded by the Netherlands Organization for Health Research and Development (ZonMw) from 2001 onward that were finalized before March 1, 2010, were studied. Of the 79 grant proposals, 50 (63%) were intervention studies, 18 (23%) were diagnostic studies, and 6 (8%) were prognostic studies. Subgroups were mentioned in 49 (62%) grant applications and in 53 (67%) publications. In 20 of the 79 projects (25%), the publications were completely in agreement with the grant proposal; that is, subgroups that were prespecified in the grant proposal were reported and no new subgroup analyses were introduced in the publications. Of the 149 prespecified subgroups, 46 (31%) were reported in the final report or scientific publications, and 143 of the 189 (76%) reported subgroups were based on post-hoc findings. For 77% of the subgroup analyses in the publications, there was no mention of whether these were prespecified or post hoc. Justification for subgroup analysis and methods to study subgroups were rarely reported. The authors conclude that there is a large discrepancy between grant applications and final publications regarding subgroup analyses. Both nonreporting prespecified subgroup analyses and reporting post-hoc subgroup analyses are common. More guidance is clearly needed.
引用
收藏
页码:219 / 225
页数:7
相关论文
共 30 条
[1]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[2]  
[Anonymous], 2010, BMJ
[3]   Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].
Assmann, SF ;
Pocock, SJ ;
Enos, LE ;
Kasten, LE .
LANCET, 2000, 355 (9209) :1064-1069
[4]   Sex and gender subgroup analyses of randomized trials - The need to proceed with caution [J].
Aulakh, Amandev K. ;
Anand, Sonia S. .
WOMENS HEALTH ISSUES, 2007, 17 (06) :342-350
[5]   Biostatistics Primer What a Clinician Ought to Know: Subgroup Analyses [J].
Barraclough, Helen ;
Govindan, Ramaswamy .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) :741-746
[6]   Misuse of baseline comparison tests and subgroup analyses in surgical trials [J].
Bhandari, Mohit ;
Devereaux, P. J. ;
Li, Patricia ;
Mah, Doug ;
Lim, Ki ;
Schuenemann, Holger J. ;
Tornetta, Paul, III .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2006, (447) :247-251
[7]  
Brookes S T, 2001, Health Technol Assess, V5, P1
[8]   Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test [J].
Brookes, ST ;
Whitely, E ;
Egger, M ;
Smith, GD ;
Mulheran, PA ;
Peters, TJ .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (03) :229-236
[9]  
BULPITT CJ, 1988, LANCET, V2, P31
[10]   WHAT DO I WANT FROM HEALTH RESEARCH AND RESEARCHERS WHEN I AM A PATIENT [J].
CHALMERS, I .
BRITISH MEDICAL JOURNAL, 1995, 310 (6990) :1315-1318